Researchers have developed COMPASS, an AI model that predicts immunotherapy response across multiple cancer types and treatments using tumor gene expression data. The model, published in Nature Medicine, was validated across independent patient cohorts, potentially enabling better treatment selection and fewer unnecessary side effects. — Photo by Google DeepMind on Unsplash (Unsplash License)
MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, Accréditation Sans Frontières (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016–2021). ORCID: 0000-0001-7609-4515.
